c-Fms-IN-7

• CAS Number:

  1313408-89-7

• UNSPSC Description:

  c-Fms-IN-7 is a cFMS inhibitor extracted from patent WO2011079076A1, example159, has an IC50 of 18.5 nM[1].

• Target Antigen:

  c-Fms

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/c-fms-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CN=C2C=C(SC)C=CN21)NC3=CC=CC4=C3C(C5CC5)=NN4CC6=NC(C)=CC=C6

• Molecular Weight:

  468.57

• References & Citations:

  [1]Mark Laurence Boys，et al. Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors. WO2011079076A1

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported